胆囊癌淋巴转移相关分子机制研究的综述
候爽1 田晓丰1 王岩1 臧洪亮1 赵民学2 王葆林1 曹宏1
1.吉林大学中日联谊医院新民院区肝胆外科,吉林长春 130000;
2.深圳市萨米医疗中心,广东深圳 518000
Review of relevant molecular mechanism of lymphatic metastasis in gallbladder cancer
HOU Shuang1 TIAN Xiaofeng1 WANG Yan1 ZANG Hongliang1 ZHAO Minxue2 WANG Baolin1 CAO Hong1
1.Department of Hepatobiliary Surgery, Xinmin District, China-Japan Union Hospital, Jilin university, Jilin Province, Changchun 130000, China;
2.Shenzhen Sami Medical Center, Guangdong Province, Shenzhen 518000, China
摘要 胆囊癌为临床常见胆道系统恶性肿瘤,恶性程度较高。多数患者早期症状不典型,确诊时已处于晚期,往往需行根治性切除术,但术后仍可能出现较高复发率。影响胆囊癌手术预后的因素包括:侵袭深度,组织学分级,淋巴及周围神经浸润和淋巴结转移。而影响胆囊癌预后的一个重要因素为淋巴转移,其分子机制目前仍不甚清楚,故需临床深入分析胆囊癌淋巴转移发生机制。现就国内外临床针对胆囊癌淋巴转移相关分子机制研究现状进行综述,以期为相关实践、研究提供参考依据。
关键词 :
胆囊癌 ,
淋巴转移 ,
机制 ,
综述
Abstract :Gallbladder cancer is a common clinical malignant tumor of the biliary system with a high degree of malignancy. For most patients, symptoms are not typical in early stage and the diagnosis has been in the late stage. So radical resection is always needed. However, the postoperative high recurrence rate still remains. Factors influencing the prognosis of surgery for gallbladder cancer include the depth of invasion, histological grade, lymphatic and peripheral nerve invasion and lymph node metastasis. Though lymphatic metastasis is an important factor which affects the prognosis of gallbladder cancer, the molecular mechanism is still unclear. Therefore, it is necessary to clinically analyze the mechanism of lymphatic metastasis in gallbladder cancer. This paper reviews the current situation of molecular mechanism on lymphatic metastasis of gallbladder cancer at home and abroad in order to provide reference for relevant practice and research.
Key words :
Gallbladder cancer
Lymphatic metastasis
Mechanism
Review
基金资助: 吉林省科技发展计划项目(20180623022TC)。
通讯作者:
曹宏(1967.2-),男,博士,吉林大学中日联谊医院新民院区肝胆胰外科主任;研究方向:新型纳米主动淋巴靶向多功能淋巴示踪剂在淋巴转移的胆道肿瘤中的应用。
作者简介 : 候爽(1992.12-),男,吉林大学中日联谊医院2017级肝胆胰外科专业在读硕士研究生;研究方向:新型纳米主动淋巴靶向多功能淋巴示踪剂在淋巴转移的胆道肿瘤中的应用。
[1] 中国抗癌协会.胆囊癌规范化诊治专家共识(2016)[J].临床肝胆病杂志,2017,22(4):611-620.
[2] 张勇,任光学,冯变喜,等.胆囊癌手术方式选择及预后因素探讨(附92例报道)[J].临床外科杂志,2017,25(6):437-440.
[3] 耿智敏,王林,陈晨,等.438例胆囊癌外科治疗及预后因素分析[J].中华消化外科杂志,2016,15(4):346-352.
[4] Hirose Y,Sakata J,Endo K,et al. A 0.8-cm clear cell neuroendocrine tumor G1 of the gallbladder with lymph node metastasis:a case report [J]. World J Surg Oncol,2018, 16(1):150.
[5] Campbell KT,Hadley DJ,Kukis DL,et al. Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications [J]. PLoS One,2017,12(7):181-184.
[6] García-Caballero M,Blacher S,Paupert J,et al. Novel application assigned to toluquinol:inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway [J]. Br J Pharmacol,2016,173(12):1966-1987.
[7] Tang J,Yang Z,Wang Z,et al. Foxp3 is correlated with VEGF-C expression and lymphangiogenesis in cervical cancer [J]. World J Surg Oncol,2017,15(1):173.
[8] Li CZ,Jiang XJ,Lin B,et al. RIP1 regulates TNF-α-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-κB-VEGF-C pathway [J]. Onco Targets Ther,2018,15(11):2875-2890.
[9] 朱锦辉,王克畏,刘金明,等.原发性胆囊癌中VEGF-C表达及与肿瘤恶性特征的相关性研究[J].浙江医学,2010,32(10):1489-1491.
[10] Hong HJ,Jiang L,Lin YF,et al. TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway [J]. Bmc Cancer,2016,16(1):240.
[11] Naim A,Pan Q,Baig MS. Matrix Metalloproteinases(MMPs)in Liver Diseases [J]. J Clin Exp Hepatol,2017,7(4):97-99.
[12] Sharma A,Sharma KL,Gupta A,et al. Gallbladder cancer epidemiology,pathogenesis and molecular genetics:Recent update [J]. World J Gastroenterol,2017,23(22):3978-3998.
[13] 薛杨,魏莉娟,徐航.WWOX对胆囊癌细胞侵袭及迁移能力的影响[J].胃肠病学和肝病学杂志,2018,27(11):101-105.
[14] Souza Freitas V,Dos Santos JN,de Andrade Santos PP,et al. Expression of matrix metalloproteinases(MMPs-2,-7,-9,and -26)and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas [J]. Eur Arch Otorhinolaryngol,2018,275(12):3075-3082.
[15] 矫树华,温艳惠.CD147和MMP-2在胆囊癌组织中的表达及意义[J].医学临床研究,2015,32(4):745-747.
[16] 李志远,叶健文,齐蕾,等.钙网蛋白在胆囊癌组织中的表达及对胆囊癌细胞生物学行为影响[J].中华普通外科杂志,2018,33(2):144.
[17] 刘驰,宋展,刘建文,等.B7-H3蛋白在胆囊癌组织中的表达及其与预后的相关性[J].中国现代普通外科进展,2018,21(1):45-47.
[18] Liu CL,Zang XX,Huang H,et al. The expression of B7-H3 and B7-H4 in human gallbladder carcinoma and their clinical implications [J]. Eur Rev Med Pharmacol Sci,2016,20(21):4466-4473.
[19] Tyagi N,Bhardwaj A,Singh AP,et al. p-21 activated kinase 4 promotes proliferation andsurvival of pancreatic cancer cells through AKT and ERKdependent activation of NF-kappaB pathway [J]. Oncotarget,2014,5(18):8778-8789.
[20] Moncho-Amor V,Ibanez de Caceres I,Bandres E,et al. DUSP1/MKP1 promotes angiogenesis,invasion and metastasis in nonsmall-cell lung cancer [J]. Oncogene,2011, 30(6):668-678.
[21] Gil-Araujo B,Toledo Lobo MV,Gutierrez-Salmeron M,et al. Dual specifcity phosphatase 1 expression inversely correlates with NF-kappaB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism [J]. Mol Oncol,2014,8(1):27-38.
[22] Shen J,Zhou S,Shi L,et al. DUSP1 inhibits cell proliferation,metastasis and invasion and angiogenesis in gallbladder cancer [J]. Oncotarget,2017,8(7):12133-12144.
[23] Azoitei N,Becher A,Steinestel K,et al. Abstract 1809:PKM2 promotes tumor angiogenesis by regulating HIF-1alpha through NF-kappaB activation [J]. Cancer Research,2017,77(13):1809-1809.
[24] 刘苗苗,邱刚,房保栓,等.肿瘤相关巨噬细胞和缺氧诱导因子-1α在宫颈鳞癌中表达及其临床意义[J].现代中西医结合杂志,2018,27(3):264-266.
[25] 李永川,祁青玲,艾小庆,等.子宫内膜癌中缺氧诱导因子-1α和血管内皮生长因子-D的表达及临床意义[J].中国老年学,2017,37(17):4284-4286.
[26] Cai Q,Wang Z,Wang S,et al. Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1α via miR-138 [J]. Open Biol,2017,7(1):160247.
[27] Wu WD,Hu ZM,Shang MJ,et al. Cordycepin Down-Regulates Multiple Drug Resistant (MDR)/HIF-1α through Regulating AMPK/mTORC1 Signaling in GBC-SD Gallbladder Cancer Cells [J]. Int J Mol Sci,2014,15(7):12778-12790.
[28] 李仁锋,叶健文,齐蕾,等.低氧诱导因子-1α在胆囊癌组织中的表达及其在二甲双胍抑制胆囊癌转移中的作用[J].中华肝胆外科杂志,2017,23(6):383.
[29] Takahashi T,Shivapurkar N,Riquelme E,et al. Aberrant Promoter Hypermethylation of Multiple Genes in Gallbladder Carcinoma and Chronic Cholecystitis [J]. Clin Cancer Res,2015,10(1):6126-6133.
[30] 孔雷,徐瑞云,吴庆华,等.胆囊癌组织多个肿瘤相关基因甲基化的检测及其意义[J].肝胆胰外科杂志,2019, 31(2):40-44.
[31] 陈晨,慎浩鑫,陶杰,等.肿瘤相关成纤维细胞对胆囊癌细胞生长和侵袭的影响[J].南方医科大学学报,2015, 35(8):1149-1154.
[1]
郭灶耿1,2 孟瑞伟2 汪志宏1,2. 脑卒中复发相关影响因素研究进展 [J]. 中国医药导报, 2020, 17(9): 41-44,48.
[2]
徐琪 付佳 韩睿. SGLT-2抑制剂治疗糖尿病肾病的研究进展 [J]. 中国医药导报, 2020, 17(8): 21-24.
[3]
付佳 徐琪 韩睿. 维生素D及其受体在糖尿病肾病发病中的研究进展 [J]. 中国医药导报, 2020, 17(7): 23-26.
[4]
刘兴慈1 苏克雷2 张业清1,2 朱梦月1 刘茜1 曹亚坤1 何孔琴1. 基于肠道微生态角度探讨中医药治疗社区获得性肺炎的作用机制 [J]. 中国医药导报, 2020, 17(7): 39-42.
[5]
王江威1 苏晓琳1 赵婉1 王秋红1,2. 中药治疗胰腺癌的临床应用及作用机制研究进展 [J]. 中国医药导报, 2020, 17(7): 31-34.
[6]
周谦 苏娟▲ 季梦遥. 非酒精性脂肪性肝病的治疗研究进展 [J]. 中国医药导报, 2020, 17(6): 26-29.
[7]
莫雪蕊1 陈君超2 金铭1 魏建子1 毛慧娟1. 传统艾灸艾烟安全性的研究进展 [J]. 中国医药导报, 2020, 17(6): 23-25,43.
[8]
南锐伶1,2 裴菊红1 韩春彦1 陈海霞1,3 张亚斌1 苟玲1 豆欣蔓1,4. 我国静脉治疗专科护士培养的研究进展 [J]. 中国医药导报, 2020, 17(6): 44-47.
[9]
程玉1 谭诗云2 李明2 马凤梅1. 具核梭杆菌与结直肠癌相关性的研究进展 [J]. 中国医药导报, 2020, 17(3): 30-33.
[10]
朱礼敬 吕利明 刘培培 杨昕宇 王硕 尚艳丽. 护生职业决策自我效能的特点及相关研究进展 [J]. 中国医药导报, 2020, 17(2): 41-43,47.
[11]
思飞1 张玲1 李盼1 马莉2. 脓毒症心肌细胞凋亡的线粒体机制研究进展 [J]. 中国医药导报, 2020, 17(2): 44-47.
[12]
肖强1 郭子龙1 许宁宁2. 加味独活寄生汤联合塞来昔布治疗膝骨性关节炎的效果 [J]. 中国医药导报, 2020, 17(11): 149-152.
[13]
武明云1,2 虞坚尔1 白莉3 薛征1,3 蒋沈华1,2 徐万超1,2. 基于NF-κB信号通路中药治疗支气管哮喘的实验研究进展 [J]. 中国医药导报, 2020, 17(10): 31-34.
[14]
刘杨 朱斌▲ 何健 周群. 意外胆囊癌的影像学特征及误漏诊分析 [J]. 中国医药导报, 2020, 17(1): 161-164.
[15]
赵军1 张晓峰2 徐西林2 王政春1 缴健菲3 房祥春1 贺雪峰1 贾寻源4. 不同类型股骨头坏死的microRNA研究进展 [J]. 中国医药导报, 2019, 16(9): 30-33.